Actively Recruiting
DRIVing Simulator and People With NeuroCognitive Disorders
Led by University Gustave Eiffel · Updated on 2024-03-20
150
Participants Needed
1
Research Sites
157 weeks
Total Duration
On this page
Sponsors
U
University Gustave Eiffel
Lead Sponsor
H
Hospices Civils de Lyon
Collaborating Sponsor
AI-Summary
What this Trial Is About
The ageing of the population is leading to an increasing number of older drivers on the roads. At the same time, the proportion of older people with pathological ageing and neurocognitive disorders (NCD) is increasing. In terms of road safety, this raises the question of whether these drivers should continue to drive or not. People with NCDs may not be aware of the presence, extent and progression of their cognitive impairment and the impact it can have on daily life, including driving. Despite their loss of autonomy and medical advice, 22% of people with major NCD continue to drive. In addition, the presence of minor NCD also puts people at a higher risk of road accidents. However, several studies demonstrated that an NCD does not lead to a systematic and immediate impairment of driving ability and abruptly stopping driving leads to health problems, such as the risk of depression and greatly reduces quality of life. It is therefore relevant to focus research on driving with people with NCD in order to have a reliable indicator of the person's abilities and the impact of their cognitive impairment on driving activity. The proposed study seeks to meet this need by studying the performance of people with NCD on a driving station (mini-simulator) while assessing their ability to evaluate their performance. To achieve this goal, people with NCDs will perform tasks on a driving simulator. In addition, after each task on the driving simulator, they will answer questions about how they evaluate their own driving. Two assessors will observe the participants' driving and will estimate their driving performance. By comparing the driver's self-assessment with the assessors' assessment, an "awareness score of driving ability" will be calculated to determine whether the driver correctly assessed his or her performance. Another project already underway aims to collect similar data from people without a diagnosis of NCDs (control group). The principal objective of the present study is to compare the driving performance in a simulator and the awareness of driving ability of people with NCDs with those of a control group. Secondary objectives are : 1. to measure driving performance in a simulator and awareness of driving abilities (i.e. self-assessment skills) of people with NCDs. 2. to analyse driving performance and awareness of driving abilities according to the diagnosis and severity of the disorder (i.e. minor or major neurocognitive disorders). 3. to establish a methodology to identify a driver at risk of dangerous driving. It is mainly an exploratory study however some hypotheses can be made : * The driving performance and awareness of driving skills of people with NCDs are poorer compared to those of older, control individuals. * Individuals' driving performance and awareness of driving ability are lower in the presence of major NCDs compared to minor NCDs.
CONDITIONS
Official Title
DRIVing Simulator and People With NeuroCognitive Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Neurocognitive Disorders according to the Diagnostic and Statistical Manual of Mental Disorders-V (DSM-V)
- Normal or corrected vision
- Holder of a B driving license with at least 3 years of driving experience
- Active drivers or those who stopped driving less than 2 months ago
- Able to provide written informed consent or have consent provided by legal representative or curator if under tutelage
- Affiliated with a social security scheme
You will not qualify if you...
- History of epilepsy
- Vestibular disorders, motion sickness, or migraines
- Psychiatric history such as schizophrenia
- Unstable use of antidepressants or anxiolytics started or changed within the last 3 months
- History of alcoholism
- Use of anti-epileptic medications
- Osteo-articular conditions that impair walking
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hôpital des Charpennes
Villeurbanne, France, 69100
Actively Recruiting
Research Team
M
Maud Ranchet, PhD
CONTACT
M
Marion Giroux, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here